For research use only. Not for therapeutic Use.
SOP1812（Cat No.:I042915）is a novel small molecule inhibitor designed to target specific enzymes or receptors involved in cancer and other diseases. It works by modulating critical signaling pathways that regulate cell survival, proliferation, and apoptosis, which are often dysregulated in tumor cells. SOP1812 has demonstrated promising results in preclinical studies for its ability to inhibit tumor growth and enhance the effectiveness of conventional cancer treatments. Researchers are investigating its potential therapeutic applications in oncology, particularly for tumors with specific molecular profiles, aiming to provide more targeted and effective treatment options.
| CAS Number | 2546091-70-5 |
| Synonyms | 14-hydroxy-6,13-bis(3-morpholin-4-ylpropyl)-10-(2-pyrrolidin-1-ylethylimino)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),2,4(16),8,11(15)-pentaene-5,7,12-trione |
| Molecular Formula | C45H57N7O6 |
| Purity | ≥95% |
| IUPAC Name | 14-hydroxy-6,13-bis(3-morpholin-4-ylpropyl)-10-(2-pyrrolidin-1-ylethylimino)-3-[4-(pyrrolidin-1-ylmethyl)phenyl]-6,13-diazatetracyclo[6.6.2.04,16.011,15]hexadeca-1(14),2,4(16),8,11(15)-pentaene-5,7,12-trione |
| InChI | InChI=1S/C45H57N7O6/c53-42-35-29-34(33-9-7-32(8-10-33)31-50-14-3-4-15-50)40-38-36(43(54)51(44(40)55)18-5-16-48-21-25-57-26-22-48)30-37(46-11-20-47-12-1-2-13-47)41(39(35)38)45(56)52(42)19-6-17-49-23-27-58-28-24-49/h7-10,29-30,53H,1-6,11-28,31H2 |
| InChIKey | TZQVPFRBHPQZNM-UHFFFAOYSA-N |
| SMILES | C1CCN(C1)CCN=C2C=C3C4=C(C(=CC5=C(N(C(=O)C2=C54)CCCN6CCOCC6)O)C7=CC=C(C=C7)CN8CCCC8)C(=O)N(C3=O)CCCN9CCOCC9 |
